Michael J. Salvino - Jun 1, 2021 Form 4 Insider Report for DXC Technology Co (DXC)

Role
President and CEO, Director
Signature
William L. Deckelman, Jr., Attorney-in-Fact
Stock symbol
DXC
Transactions as of
Jun 1, 2021
Transactions value $
-$2,000,723
Form type
4
Date filed
6/3/2021, 07:53 PM
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXC Common Stock Award $0 +120K +24.51% $0.00 608K Jun 1, 2021 Direct F1, F2
transaction DXC Common Stock Tax liability -$770K -19.4K -3.19% $39.76 589K Jun 2, 2021 Direct F2, F3
transaction DXC Common Stock Tax liability -$1.23M -31K -5.26% $39.76 558K Jun 2, 2021 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest in three equal annual installments beginning June 1, 2022.
F2 Amount reported includes unvested RSUs.
F3 Shares withheld to satisfy tax liabilities arising from the vesting and settlement of 43,319 RSUs awarded on June 2, 2020 that vested on June 2, 2021 in the first of three equal annual installments.
F4 Shares withheld to satisfy tax liabilities arising from the vesting and settlement of 69,252 performance-vesting RSUs awarded on October 1, 2020 upon the consummation of the sale by DXC Technology Company of its U.S. State and Local Health and Human Services Business, that vested on June 2, 2021 in the second installment. The third and last installment will vest on June 2, 2022.